Alamar Biosciences Inc
Follow $ALMR
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ALMR by emailVeridion Score
BETALOW CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is ALMR moving today?
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
ALMR overview
Related filings and maps
Congress activity in ALMR
No receipt-qualified Congressional disclosure is present for ALMR in the cached public ledger.
ALMR contract awards, year to date.
Public federal awards linked to this ticker.
NULISASEQ NEURO 220 PANEL. MULTIPLEXED PRECISION PROTEOMICS IMMUNOASSAY PANEL FOR NEU...
ALAMAR BIOSCIENCES, INC.:1334504 [26-010199]
ALMR lobbying filings, year to date.
Registered lobbying filings matched to Alamar Biosciences Inc.